An experimental model to study intracranial hypertension-induced vomiting in conscious dogs

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue 5, 1996, Pages 315-320

  Kacker, Vineet ^a   Gupta, Yogendra Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Intracranial hypertension; Intracranial pressure (ICP); Retching; Vomiting

Indexed keywords

ONDANSETRON; PRAZOSIN; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOG; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PATHOPHYSIOLOGY; TREATMENT OUTCOME; VOMITING;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOGS; FEMALE; INTRACRANIAL PRESSURE; MALE; ONDANSETRON; PRAZOSIN; PROPRANOLOL; PSEUDOTUMOR CEREBRI; SEROTONIN ANTAGONISTS; VOMITING;

EID: 0030036362     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. McGilicuddy, J.E. Cerebral protection: Pathophystology and treatment of increased intracranial pressure. Chest 1985, 16:85-93.
2. Livingston, E.H., Passaro, E.F., Garrick, T. Elevated intracranial pressure stimulates gasiric contractility in the rat. J Surg Res 1991, 50. 106-10.
3. Matthews, D.E., Heimansohn. D.A., Papaila, J.G. et al. The effect of increased intracranial pressure (ICP) on gasiric motility. J Surg Res 1988, 45. 60-5.
4. Ando, S., Otani, M., Montake, K. Clinical analysis of posttraumatic vomiting. Acta Neurochir 1992, 119: 97-100.
5. Belville, J.W., Bross, I.D.J., Howland, W.S. Postoperative nausea and vomiting IV: Factors related to postoperative nausea and vomiting. Anaesthesiology 1960, 21: 186-93.
6. Seigel, L.J., Longo, D.L. The control of chemotherapv induced emests. Ann Intern Med 1981. 95: 352-9.
7. Brown, F.D., Jaffar, J.J., Kreiger, K. et al. Cardiac and cerebral changes following experimental head injury. In. Head Injury Basic and Clinical Aspects. Grossman, R.G., Gildenberg. P.E. (Eds.). Raven Press: New York 1982, 151-7.
8. Rosner, M.J., Newsome, H.H., Becker, D.P. Mechanical brain injury: The sympathoadrenal response. J Neurosurg 1984, 61: 76-86.
9. Soblosky, J.S., Roger, N.L., Adams, J.A. et al. Central and peripheral biogenic amine effects of brain missile wounding and increased intracranial pressure. J Neurosurg 1992, 76: 119-26.
10. Gonella, J., Niel, P., Roman, C. Sympathetic control of the , lower oesophageal sphincter motility in the cat. J Physiol 1979, 287: 177-90.
11. Zfass, A.M., Prince, M., Allen, F.N., Parrar, J.T. Inhibitory β-adrenergic receptors in the human distal esophagus. Amer J Dig Dis 1970. 15: 303-10.
12. Furness, J.B., Costa, M. The adrenergic innervation of the gastrointestinal tract. Ergebn Physiol Biol Chem Exp Pharmacol 1974, 69: 1-51.
13. Gillespie, J.S., Khoyi, M.A. The site and receptors responsible for the inhibition by sympathetic nerves of intestinal smooth muscle and its parasympathetic motor nerve. J Physiol 1977, 267: 767-89.
14. Abrahamsson, H., Glise, H Sympathetic nervous control of gastric motility and interaction with vagal activity. Scand J Gastroenterol 1984, 19 (Suppl. 89): 83-7.
15. Garrick, T., Mulvihill, S., Buack, S., Maeda-Hagiwara, M., Tache, Y. Intracerebroventricular pressure inhibits gastric antral and duodenal contractility but not acid secretion in conscious rabbits. Gastroenterology 1988, 95: 26-31.
16. Jenkins, L.C., Lahay, D. Central mechanisms of vomiting related to catecholamine response: Anesthetic implications. Can Anaesth Soc J 1971, 18: 434-41.
17. Cavero, I., Roach, A.G. The effects of prazosin on the clontdine induced hypotension and bradycardia in rats and sedation in chicks. Brit J Pharmacol 1978, 62: 468-9P.
18. Stanaszek, W.F., Kellerman, D., Brogden. R.N., Romankiewicz. J. A. Prazosin update: A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs 1983, 25: 339-84.
19. 3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Brit J Pharmacol 1989, 97: 247-55.
20. 3 receptors, Med Res Rev 1990, 10: 441-75.
21. Milne, R.J., Heel, R.C. Ondansetron. Therapeutic use as an anti-emetic. Drugs 1991, 41: 574-95.
22. 3 antagonists in postoperative nausea and vomiting. Brit J Anaesth 1992, 69 (Suppl. 1): 63-8S.
23. Costall, B., Domeney, A.M., Gunning, S.J., Naylor R.J., Tattersall, F.D., Tyers, M.B. GR 38032F: A potent and novel inhibitor of cisplatin-induced emesis in the ferret. Brit J Pharmacol 1987, 90: 90P.
24. 3 receptor antagonist prevents cisplatin induced emesis in dogs. Meth Find Exp Clin Pharmacol 1989, 11: 361-3.